Experts Push for Earlier Chronic Kidney Disease Detection

Medical professionals are calling for new screening protocols to identify asymptomatic kidney disease before it reaches advanced stages.

Updated on Oct. 29, 2026 in Diabetes

A modern metallic diagnostic instrument on a clean laboratory table, representing advanced healthcare technology for early disease detection.
The American Society of Nephrology is calling for updated screening protocols to identify chronic kidney disease earlier, aiming to improve the effectiveness of emerging therapeutic interventions. AI Illustration. Upload story photo >

Live Poll

Should the government implement mandatory national screening programs for chronic kidney disease?

Experts at the American Society of Nephrology Kidney Week meeting are advocating for improved early detection methods for chronic kidney disease. They emphasized that new therapeutic options are most effective when administered before patients reach end-stage conditions.

Why it matters

Earlier detection is essential to utilize emerging treatments effectively, as current standard guidelines do not mandate routine urine testing for asymptomatic individuals. Shifting toward proactive screening could prevent disease progression that remains hidden until advanced stages.

Experts estimate a 17-year gap exists between established clinical evidence and the routine adoption of SGLT2 inhibitors in medical practice. Currently, no national targeted screening programs for chronic kidney disease exist in the United States.

The players

American Society of Nephrology

This professional organization represents kidney health experts and hosts the annual Kidney Week meeting to share advancements in nephrology.

The details

Researchers are proposing precision approaches that utilize biomarkers, big data, and artificial intelligence to monitor treatment responses and identify high-risk patients. These methods aim to move beyond the current diagnostic standard, which requires a nephrologist to perform a biopsy for conditions like IgA nephropathy.

Timeline

  1. October 2026: Experts convened for the American Society of Nephrology Kidney Week meeting.

The Big Picture

The American Society of Nephrology Kidney Week meeting acts as the primary forum for discussing the implementation of precision medicine in nephrology. This discussion follows the trend set by the meeting to integrate data-driven diagnostics into standard care.

Patients may eventually benefit from earlier diagnoses that allow for the use of new therapies before kidney damage becomes irreversible. Individuals should consult their primary care providers about whether current routine health screenings are sufficient for their specific risk profile.

The takeaway

Proactive monitoring for kidney health remains a challenge because the condition often lacks symptoms in its early stages. Patients are encouraged to discuss their kidney function tests with their doctors during routine physical exams to ensure any potential issues are caught early.

Further reading

Learn more about the latest innovations in kidney health on the Diabetes page.

Source note: This article includes information reported by Ajmc.

Live Poll

Should the government implement mandatory national screening programs for chronic kidney disease?